High performance, broad applicability, quantitative potency Join us for this webinar to get the latest news about the in vitro GARD assays and how they are used to fill data gaps and address challenges in skin sensitization testing, such as “difficult-to-test” substances, quantitative potency assessment, testing of medical devices and solid materials. Key topics An […]
In this webinar, our Medical Device and ISO expert Dr Rose-Marie Jenvert will tell you more about how you can use in vitro methods for the biological evaluation of medical devices, now offered at our GLP certified laboratories. She will also introduce you to our expanded medical device offering and how we can help you […]
Meet us at the 2022 SOT Annual Meeting & ToxExpo Booth #1207 @ San Diego Convention Center, San Diego, USA Are you attending the 2021 Society of Toxicology Annual Meeting? Come join our hosted session and poster presentations to hear the latest news about GARD™ and how the assays are used for skin sensitization testing. […]
The leading global event for personal care ingredients April 5-7 | Porte de Versailles, Paris | Booth: P102 Meet SenzaGen and partners PKDERM, GenEvolutioN, WatchFrog and CEHTRA at in-cosmetics Global in Paris to find out about our latest innovations for safety and efficacy evaluation of cosmetics and ingredients!
New GARD® data on agrochemical formulations, fragrance materials, medical devices and metals - Skin sensitization: using in vitro tools for quantitative potency assessment as an alternative to the Local Lymph Node Assay In case you missed SenzaGen’s scientific session at this year’s SOT, here is a new opportunity! Together with guest speakers from Takasago and […]
Case studies on 3D reconstructed human tissues This webinar will showcase the opportunities offered by 3D reconstructed human tissues to demonstrate the physical mode of action of medical devices in line with the requirements and ethical criteria of the EU Medical Devices Regulation (MDR) 2017/745. Key takeaways Attendees will gain insights into: 💡 How the principles […]
Join this live webinar led by our skin sensitization specialist Dr Andy Forreryd to learn the features and benefits of GARDskin and how the method can be used to fill data gaps during regulatory testing and product development. GARDskin approved by OECD We are delighted to announce that SenzaGen's GARDskin assay has been adopted by […]
Drug device combination products and substance-based medical devices Sep 14 | Copenhagen, Denmark Medicon Valley Alliance, together with member company Innokas Medical, have the pleasure to invite you to the Medicon Valley Alliance MedTech Network meeting, on the 14th of September, focusing on drug-device combination products and substance-based medical devices. Sign up here The market […]
2022 International Congress of Toxicology - "Uniting in Toxicology" Discussions at this year's ICT New opportunities for skin sensitization testing with GARDskin OECD TG 442E Come visit us at our booth and join our industry symposium to learn how the high performance and broad applicability of the GARDskin method bring new opportunities to the field […]
Oct 5-6 | Copenhagen, Denmark Meet SenzaGen at 2022 Biocompatibility Matters, a two-day conference in Copenhagen. SenzaGen's Medical Device specialist and ISO expert Dr Rose-Marie Jenvert will speak on the topic “New approaches to in vitro sensitization – regulatory acceptance”. Key takeaways: * An introduction to in vitro assays for skin sensitization, ISO 10993-10 * […]
